GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Komipharm International Co Ltd (XKRX:041960) » Definitions » Interest Expense

Komipharm International Co (XKRX:041960) Interest Expense : ₩-2,637 Mil (TTM As of Sep. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Komipharm International Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Komipharm International Co's interest expense for the three months ended in Sep. 2024 was ₩ -783 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2024 was ₩-2,637 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Komipharm International Co's Operating Income for the three months ended in Sep. 2024 was ₩ 897 Mil. Komipharm International Co's Interest Expense for the three months ended in Sep. 2024 was ₩ -783 Mil. Komipharm International Co's Interest Coverage for the quarter that ended in Sep. 2024 was 1.14. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Komipharm International Co Interest Expense Historical Data

The historical data trend for Komipharm International Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Komipharm International Co Interest Expense Chart

Komipharm International Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,908.85 -1,549.45 -1,656.53 -2,216.08 -2,551.95

Komipharm International Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -758.48 -730.20 -328.11 -795.11 -783.37

Komipharm International Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-2,637 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Komipharm International Co  (XKRX:041960) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Komipharm International Co's Interest Expense for the three months ended in Sep. 2024 was ₩-783 Mil. Its Operating Income for the three months ended in Sep. 2024 was ₩897 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2024 was ₩6,214 Mil.

Komipharm International Co's Interest Coverage for the quarter that ended in Sep. 2024 is calculated as

Interest Coverage=-1* Operating Income (Q: Sep. 2024 )/Interest Expense (Q: Sep. 2024 )
=-1*896.797/-783.37
=1.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Komipharm International Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Komipharm International Co Ltd (XKRX:041960) » Definitions » Interest Expense
Comparable Companies
XKRX:000520 XKRX:033270 XKRX:256840 XKRX:102940 XKRX:058820 XKRX:001630 XKRX:102460 XKRX:176750 XKRX:003220 XKRX:005500 ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XTAE:TEVA NSE:DIVISLAB XSWX:SDZ VTRS
Traded in Other Exchanges
N/A
Address
1236-6 Jungwang-Dong, Sihung, Gyeonggi, KOR, 429-450
Website
http://www.komilab.co.kr
Komipharm International Co Ltd is involved in the healthcare sector based in Korea. Its core business includes development and manufacture of veterinary vaccines and veterinary pharmaceuticals. The company produces its products under two divisions: veterinary vaccines such as total vaccines of respiratory disease for swine, vaccines of anthrax disease and black leg for cattle. The other division is made up of veterinary pharmaceuticals such as antibiotics, nutrients, disinfectants and others, which are used to treat pneumonia, pasteurellosis, enteritis, mastitis and swine erysipelas.

Komipharm International Co Headlines

No Headlines